Trexquant Investment LP Biomarin Pharmaceutical Inc Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

A detailed history of Trexquant Investment LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Trexquant Investment LP holds 310,702 shares of BMRN stock, worth $19.7 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

310,702

Previous 130,501 138.08%

Holding current value

$19.7 Million

Previous $10.7 Million 103.27%

% of portfolio

0.29%

Previous 0.17%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$69.02 - $93.84 $12.4 Million - $16.9 Million	180,201 Added 138.08%	310,702 $21.8 Million
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $8.48 Million - $10.5 Million	113,896 Added 685.91%	130,501 $10.7 Million
Q1 2024 May 14, 2024	BUY	$83.81 - $99.0 $1.39 Million - $1.64 Million	16,605 New	16,605 $1.45 Million
Q3 2023 Nov 13, 2023	SELL	$85.07 - $94.48 $5.12 Million - $5.69 Million	-60,175 Reduced 49.41%	61,605 $5.45 Million
Q2 2023 Aug 11, 2023	BUY	$86.68 - $100.3 $10.6 Million - $12.2 Million	121,780 New	121,780 $10.6 Million
Q2 2022 Aug 11, 2022	SELL	$71.48 - $86.85 $2.6 Million - $3.16 Million	-36,379 Reduced 91.1%	3,555 $295,000
Q1 2022 May 13, 2022	BUY	$74.28 - $92.69 $2.97 Million - $3.7 Million	39,934 New	39,934 $3.08 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $2.58 Million - $3.29 Million	-35,967 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $1.94 Million - $2.22 Million	25,943 Added 258.81%	35,967 $2.78 Million
Q2 2021 Aug 12, 2021	SELL	$75.51 - $84.79 $278,933 - $313,214	-3,694 Reduced 26.93%	10,024 $836,000
Q1 2021 May 13, 2021	BUY	$74.73 - $90.69 $1.03 Million - $1.24 Million	13,718 New	13,718 $1.04 Million
Q4 2020 Feb 11, 2021	SELL	$72.61 - $90.2 $642,888 - $798,630	-8,854 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$71.87 - $131.03 $836,782 - $1.53 Million	-11,643 Reduced 56.8%	8,854 $674,000
Q2 2020 Aug 07, 2020	BUY	$79.55 - $124.22 $246,764 - $385,330	3,102 Added 17.83%	20,497 $2.53 Million
Q1 2020 May 08, 2020	BUY	$71.37 - $96.85 $1.24 Million - $1.68 Million	17,395 New	17,395 $1.47 Million
Q3 2019 Nov 08, 2019	SELL	$67.4 - $85.11 $1.49 Million - $1.88 Million	-22,049 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$80.35 - $93.9 $1.77 Million - $2.07 Million	22,049 New	22,049 $1.89 Million
Q2 2018 Aug 07, 2018	SELL	$76.01 - $99.03 $1.02 Million - $1.33 Million	-13,397 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$77.67 - $92.63 $1.04 Million - $1.24 Million	13,397 New	13,397 $1.09 Million

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Biomarin Pharmaceutical Inc Transaction History